Active	Status	Sponsor type	Region	Phase	Filter
6 Active 4 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Milla, Carlos E
NCT06159725: A Study to Evaluate the Safety of CMTX-101 in People with Cystic Fibrosis	Recruiting	1/2	41	US	CMTX-101, Placebo	Clarametyx Biosciences, Inc.	Persistent Infection, Cystic Fibrosis	08/25	08/25
NCT06016088: A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection	Recruiting	1/2	72	US, RoW	RSP-1502, Tobramycin inhalation solution	Respirion Pharmaceuticals Pty Ltd	Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa	12/25	12/25
NCT03894228: Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)	Recruiting	N/A	1750	Europe		Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa, Spanish Agency of Medicines and Health Products	Inflammatory Bowel Diseases, Pregnancy	03/24	03/28
STOP PEDS RCT, NCT06654752: Streamlined Treatment of Pulmonary Exacerbations in Pediatrics	Recruiting	N/A	430	Canada, US	Immediate Oral Antibiotics, Tailored Treatment: Oral Antibiotics only if Additional Treatment needed	University of Washington, the Collaborative Health Studies Coordinating Center, Cystic Fibrosis Foundation	Cystic Fibrosis	12/27	02/29
Schwarzenberg, Sarah J
NICE-CF, NCT05362344: Colorectal Cancer Screening in Cystic Fibrosis	Active, not recruiting	N/A	350	US	Stool tests, Stool-based Fecal Immunochemical Testing (FIT) test and Stool-based DNA test (Cologuard) test.	University of Washington, the Collaborative Health Studies Coordinating Center, Cystic Fibrosis Foundation	Cystic Fibrosis, Colorectal Cancer, Adenoma	03/25	06/25
Mahan, Kathleen
NCT06016088: A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection	Recruiting	1/2	72	US, RoW	RSP-1502, Tobramycin inhalation solution	Respirion Pharmaceuticals Pty Ltd	Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa	12/25	12/25